About us

Our values

Ambition & willingess
to make an impact

We strive to use our unique science to discover new therapeutic molecules to improve patients lives.

Curiosity &
multi-disciplinarity

We are genuinely interested in working with people from diverse backgrounds. That's how together, we'll invent the best molecules.

Progression &
feedback

We challenge and solicit feedback from each other to constantly improve.

Scientific approach
& rigor

We maintain high scientific standards in all our projects and research.

Team

Aqemia was founded by Maximilien Levesque and Emmanuelle Martiano with the aim of disrupting the drug discovery industry, by leveraging proprietary algorithms developed by Maximilien to quickly and accurately predict the affinity between drug candidates and therapeutic targets. This technology is the product of 8 years of academic research that he conducted at the École normale supérieure - PSL on a quantum and statistical mechanics theory to calculate free energies.

CEO & co-founder
Maximilien Levesque
Blog Author

I spent 9 years as a researcher in quantum / statistical physics and AI at the École normale supérieure - PSL, CEA Saclay (PhD in 2010), Cambridge, Oxford and CNRS. I am the inventor of Aqemia's core technology.

COO & co-founder
Emmanuelle Martiano
Blog Author

I spent 9 years at strategy consulting firm BCG, leading projects for corporate leaders in the pharma industry and in B2B software. I graduated from the École Centrale Supélec and Imperial College of London.

Senior Advisors

senior advisor
Jean-Marc Herbert, PhD
Former Senior VP Head of Discovery at Sanofi, Venture Partner at Go Capital, 25+ years experience in drug discovery
senior advisor
Francis Bach, PhD
”Académicien des Sciences”, Research group leader at Inria, Specialist in machine learning and optimization with over 20+ years of experience

They support us